Radiation for Mesothelioma: Could Proton Therapy Be the Answer?

Researchers at the Maryland Proton Therapy Treatment Center say that a highly-targeted version of proton beam radiation could be the future of radiotherapy for malignant plural mesothelioma.

Advanced Oncotherapy (LON:AVO), is developing a unique, fully integrated, proton therapy system. The LIGHT System is expected to be the first commercially available linear proton accelerator for medical treatment of cancer patients.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Advanced Oncotherapy Plc

    More articles like this

    Hardman & Co

    ADVANCED ONCOTHERAPY Nearing the end goal

    AVO’s goal is to deliver an affordable and novel proton beam therapy (PBT) system, based on state-of-the-art technology developed originally at the world-renowned CERN. 2018 was characterised by the achievement of a number of technical milestones,

    Hardman & Co

    Advanced Oncotherapy Commercialising a breakthrough technology

    Advanced Oncotherapy (LON:AVO) goal is to deliver an affordable and novel proton beam therapy (PBT) system, based on state-of-the-art technology developed originally at the world-renowned CERN. 2018 was characterised by achievement of a number of technical milestones,

    Hardman & Co

    Advanced Oncotherapy Preparing for commercialisation

    Advanced Oncotherapy (LON:AVO) goal is to deliver an affordable and novel proton beam therapy system (PBT), based on state-of-the-art technology developed originally at the world-renowned CERN. 2018 was characterised by the achievement of a number of

    Hardman & Co

    Advanced Oncotherapy Important regulatory milestone: ISO approval

    Advanced Oncotherapy (LON:AVO)  goal is to deliver an affordable and novel proton therapy (PT) system, based on state-of-the-art technology developed originally at the CERN. Achievement of major technical milestones has boosted confidence, and the group remains

    Hardman & Co

    Advanced Oncotherapy Four components integrated

    Advanced Oncotherapy (LON:AVO)  goal is to deliver an affordable and novel proton therapy system (PT), based on state-of-the-art technology developed originally at the world-renowned CERN. Achievement of major technical milestones has boosted confidence greatly, and the

    Advanced Oncotherapy Plc

    University Hospitals hitting mark with proton therapy

    While some proton therapy centres across the country have reportedly struggled to stay profitable, officials at University Hospitals say they’ve found the “sweet spot” two years after the Cleveland-based health system opened its own $30 million

    Advanced Oncotherapy Plc

    Advanced Oncotherapy a Significant Year

    Nicolas Serandour, CEO of Advanced Oncotherapy, said: “The technological development of our LIGHT system remains on-track and we continue to proceed with a significantly reduced overall technology risk profile. Similarly work at Harley Street remains on

    Advanced Oncotherapy Plc

    90-tonne cancer-fighting cyclotron arrives in London

    A 90-tonne piece of cancer-fighting equipment that will improve the lives of hundreds of cancer patients every year has been carefully lowered into place in its new home. The cyclotron is the size of a family

    Advanced Oncotherapy Plc

    CERN Technology Next Generation Cancer Treatment

    STFC and Advanced Oncotherapy (LON:AVO) are collaborating in the construction of a proton therapy assembly and test facility at STFC’s Daresbury Laboratory, that will build on the technology at the heart of the Large Hadron Collider

    Advanced Oncotherapy Plc

    Proton Beam therapy to come to Isarel

    The deputy Health Minister Yaakov Litzman has ordered his ministry to finalise plans to establish a Proton Beam Therapy center in Israel. The announcement came after Litzman returned to Israel this week from a visit to

    Advanced Oncotherapy Plc

    Professor Stephen Myers: Beams of Life

    Proton therapy is a new way of beating cancer, with fewer side effects than conventional radiation treatments, explains Stephen Myers a pioneering nuclear medicine scientist & ADAM Executive Chairman at Advanced Oncotherapy PLC (LON:AVO)   Advanced Oncotherapy

    Advanced Oncotherapy Plc

    Curing Cancer with Proton Beams

      Particle accelerators do more than just particle physics research. Suzie Sheehy takes a look at the history and promise of proton therapy: using particle accelerators to fight cancer. The discovery of X-rays in 1895 was

    Advanced Oncotherapy Plc

    Advanced Oncotherapy PLC Update on Distribution Agreement Payment

    Advanced Oncotherapy Plc (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that further to the Company’s announcement of 3 April 2018, the Company has received from Yantai Cipu, through its affiliated entity Liquid

    Advanced Oncotherapy Plc

    Advanced Oncotherapy UK assembly and testing site agreement

    Advanced Oncotherapy Plc (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, announced today that is has signed a lease with the UK Government’s Science and Technology Facilities Council to establish a UK testing and